Group One Trading
FULC icon

Group One Trading’s Fulcrum Therapeutics FULC Stock Holding History

Group One Trading’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33K Sell
4,300
-1,000
-19% -$9.28K ﹤0.01% 5588
2025
Q4 		$59.9K Buy
5,300
+5,200
+5,200% +$52.9K ﹤0.01% 5445
2025
Q3 		$920 Hold
100
– – ﹤0.01% 8068
2025
Q2 		$688 Hold
100
– – ﹤0.01% 7621
2025
Q1 		$288 Sell
100
-4,000
-98% -$14.7K ﹤0.01% 7345
2024
Q4 		$19.3K Sell
4,100
-62,700
-94% -$231K ﹤0.01% 5710
2024
Q3 		$238K Buy
+66,800
New +$496K ﹤0.01% 3459
2024
Q1 		– Sell
-50,000
Closed -$338K – 7337
2023
Q4 		$338K Buy
50,000
+43,500
+669% +$193K ﹤0.01% 3400
2023
Q3 		$28.9K Buy
6,500
+5,400
+491% +$23.6K ﹤0.01% 5580
2023
Q2 		$3.63K Buy
+1,100
New +$3.23K ﹤0.01% 6853
2023
Q1 		– Sell
-2,500
Closed -$18.2K – 7445
2022
Q4 		$18.2K Buy
2,500
+2,400
+2,400% +$15.7K ﹤0.01% 5655
2022
Q3 		$1K Sell
100
-300
-75% -$2.15K ﹤0.01% 7308
2022
Q2 		$2K Sell
400
-5,700
-93% -$55.7K ﹤0.01% 7399
2022
Q1 		$144K Buy
6,100
+5,800
+1,933% +$82.1K ﹤0.01% 5132
2021
Q4 		$5K Sell
300
-11,000
-97% -$218K ﹤0.01% 7630
2021
Q3 		$319K Buy
+11,300
New +$214K ﹤0.01% 4678

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Group One Trading's FULC Position: Q1 2026 in Review

Group One Trading increased its Fulcrum Therapeutics (FULC) stake by 55% in Q1 2026, buying an estimated $176K and bringing the position to 53,756 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #3517.

Group One Trading first reported a position in FULC in Q3 2021 and has held it in 14 quarters since. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Group One Trading held 53,756 shares of Fulcrum Therapeutics worth $412K as of Q1 2026.
  • Group One Trading bought 19,006 Fulcrum Therapeutics shares in Q1 2026, an estimated $176K.
  • Fulcrum Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3517 holding.
  • Group One Trading first reported a position in Fulcrum Therapeutics in Q3 2021 and has held it in 14 quarters since.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.